These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 20603083)

  • 1. Lysine methylation regulates E2F1-induced cell death.
    Kontaki H; Talianidis I
    Mol Cell; 2010 Jul; 39(1):152-60. PubMed ID: 20603083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-mediated regulation of E2F1 in DNA damage-induced cell death.
    Xie Q; Bai Y; Wu J; Sun Y; Wang Y; Zhang Y; Mei P; Yuan Z
    J Recept Signal Transduct Res; 2011 Apr; 31(2):139-46. PubMed ID: 21320024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylation-acetylation interplay activates p53 in response to DNA damage.
    Ivanov GS; Ivanova T; Kurash J; Ivanov A; Chuikov S; Gizatullin F; Herrera-Medina EM; Rauscher F; Reinberg D; Barlev NA
    Mol Cell Biol; 2007 Oct; 27(19):6756-69. PubMed ID: 17646389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of p53 activity through lysine methylation.
    Chuikov S; Kurash JK; Wilson JR; Xiao B; Justin N; Ivanov GS; McKinney K; Tempst P; Prives C; Gamblin SJ; Barlev NA; Reinberg D
    Nature; 2004 Nov; 432(7015):353-60. PubMed ID: 15525938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lysine methylation: beyond histones.
    Zhang X; Wen H; Shi X
    Acta Biochim Biophys Sin (Shanghai); 2012 Jan; 44(1):14-27. PubMed ID: 22194010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repression of p53 activity by Smyd2-mediated methylation.
    Huang J; Perez-Burgos L; Placek BJ; Sengupta R; Richter M; Dorsey JA; Kubicek S; Opravil S; Jenuwein T; Berger SL
    Nature; 2006 Nov; 444(7119):629-32. PubMed ID: 17108971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance.
    Engelmann D; Pützer BM
    Drug Resist Updat; 2010; 13(4-5):119-31. PubMed ID: 20675184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SnapShot: Histone-modifying enzymes.
    Kouzarides T
    Cell; 2007 Nov; 131(4):822. PubMed ID: 18022374
    [No Abstract]   [Full Text] [Related]  

  • 9. The candidate tumor suppressor BTG3 is a transcriptional target of p53 that inhibits E2F1.
    Ou YH; Chung PH; Hsu FF; Sun TP; Chang WY; Shieh SY
    EMBO J; 2007 Sep; 26(17):3968-80. PubMed ID: 17690688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA damage and S phase-dependent E2F1 stabilization requires the cIAP1 E3-ubiquitin ligase and is associated with K63-poly-ubiquitination on lysine 161/164 residues.
    Glorian V; Allègre J; Berthelet J; Dumetier B; Boutanquoi PM; Droin N; Kayaci C; Cartier J; Gemble S; Marcion G; Gonzalez D; Boidot R; Garrido C; Michaud O; Solary E; Dubrez L
    Cell Death Dis; 2017 May; 8(5):e2816. PubMed ID: 28542143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2F1 transcription is induced by genotoxic stress through ATM/ATR activation.
    Carcagno AL; Ogara MF; Sonzogni SV; Marazita MC; Sirkin PF; Ceruti JM; Cánepa ET
    IUBMB Life; 2009 May; 61(5):537-43. PubMed ID: 19391166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter occupancy of MLL1 histone methyltransferase seems to specify the proliferative and apoptotic functions of E2F1 in a tumour microenvironment.
    Swarnalatha M; Singh AK; Kumar V
    J Cell Sci; 2013 Oct; 126(Pt 20):4636-46. PubMed ID: 23868976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of p53 function by SET8-mediated methylation at lysine 382.
    Shi X; Kachirskaia I; Yamaguchi H; West LE; Wen H; Wang EW; Dutta S; Appella E; Gozani O
    Mol Cell; 2007 Aug; 27(4):636-46. PubMed ID: 17707234
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Jab1 is a specificity factor for E2F1-induced apoptosis.
    Hallstrom TC; Nevins JR
    Genes Dev; 2006 Mar; 20(5):613-23. PubMed ID: 16481464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low doses of paclitaxel potently induce apoptosis in human retinoblastoma Y79 cells by up-regulating E2F1.
    Drago-Ferrante R; Santulli A; Di Fiore R; Giuliano M; Calvaruso G; Tesoriere G; Vento R
    Int J Oncol; 2008 Oct; 33(4):677-87. PubMed ID: 18813780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple lysine methylation of PCAF by Set9 methyltransferase.
    Masatsugu T; Yamamoto K
    Biochem Biophys Res Commun; 2009 Mar; 381(1):22-6. PubMed ID: 19351588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of product specificity of AdoMet methylation catalyzed by lysine methyltransferases: transcriptional factor p53 methylation by histone lysine methyltransferase SET7/9.
    Zhang X; Bruice TC
    Biochemistry; 2008 Mar; 47(9):2743-8. PubMed ID: 18260647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors.
    Terui T; Murakami K; Takimoto R; Takahashi M; Takada K; Murakami T; Minami S; Matsunaga T; Takayama T; Kato J; Niitsu Y
    Cancer Res; 2003 Dec; 63(24):8948-54. PubMed ID: 14695212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUV39H2 methylates and stabilizes LSD1 by inhibiting polyubiquitination in human cancer cells.
    Piao L; Suzuki T; Dohmae N; Nakamura Y; Hamamoto R
    Oncotarget; 2015 Jul; 6(19):16939-50. PubMed ID: 26183527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.